Remove Drug Trials Remove FDA Approval Remove Licensing
article thumbnail

Malaria Vaccine a Breakthrough Success with 77 Percent Efficacy

XTalks

Related: After 18 Years, FDA Approves Malaria Prevention Drug. It is the world’s first and only licensed malaria vaccine and also the first licensed for use against a human parasitic disease of any kind. Developing an efficacious vaccine against malaria has been a huge challenge.

article thumbnail

LQTT secures $19M; Nanox acquires Zebra Medical Vision; Takeda leads IBD drugVisus raises $20M

Delveinsight

LQTT has a portfolio of in-licensed compounds from Sanofi that prohibit serum/glucocorticoid-regulated kinase 1, or SGK1. AbbVie reported the success of two phase 3 trials of its drug trial in October and filed for FDA approval in February.

Trials 97